Jana Partners Pushes for Cooper and Bausch + Lomb Merger
ByAinvest
Tuesday, Oct 21, 2025 4:00 pm ET1min read
BLCO--
Jana Partners reportedly believes that Cooper’s two business divisions lack meaningful synergies and wants the company to pursue moves aimed at unlocking shareholder value. The size of Jana’s stake was not disclosed, but the activist is expected to advocate strongly for a restructuring [1].
The idea of merging the contact lens segment has already found a receptive audience. Brent Saunders, CEO of Bausch + Lomb, publicly expressed interest in such a combination during an interview. "A potential combination with Cooper would strengthen competition and create a more scaled company in the contact-lens segment," Saunders told The Wall Street Journal [2].
Both firms maintain sizable operations in the Greater Rochester region. CooperVision employs 1,629 people across three local sites, ranking as the region’s second-largest manufacturer. Bausch + Lomb, headquartered in Vaughan, Ontario, with U.S. corporate offices in Bridgewater, N.J., employs 1,168 people locally and approximately 13,000 worldwide, with a presence in nearly 100 countries [2].
Cooper Cos. stock price saw a rise over 4% in premarket trading Monday following the announcement. While the potential merger is still in the early stages and has not been confirmed, it reflects Jana Partners’ push for strategic changes within the company.
COO--
Activist investor Jana Partners has built a stake in Cooper Cos. and plans to push for strategic alternatives, including a potential combination of its contact-lens unit with rival Bausch + Lomb. Jana also aims to improve capital allocation and returns. Cooper Cos. makes contact lenses and vision-care products through CooperVision and provides products and services for women's health and fertility through CooperSurgical.
Activist investor Jana Partners has built a stake in Cooper Cos. (NASDAQ: COO) and plans to push for strategic alternatives, including a potential combination of its contact-lens unit with rival Bausch + Lomb. Jana also aims to improve capital allocation and returns. Cooper Cos. operates through CooperVision, a leading producer of soft contact lenses, and CooperSurgical, which provides women’s health and fertility products and services.Jana Partners reportedly believes that Cooper’s two business divisions lack meaningful synergies and wants the company to pursue moves aimed at unlocking shareholder value. The size of Jana’s stake was not disclosed, but the activist is expected to advocate strongly for a restructuring [1].
The idea of merging the contact lens segment has already found a receptive audience. Brent Saunders, CEO of Bausch + Lomb, publicly expressed interest in such a combination during an interview. "A potential combination with Cooper would strengthen competition and create a more scaled company in the contact-lens segment," Saunders told The Wall Street Journal [2].
Both firms maintain sizable operations in the Greater Rochester region. CooperVision employs 1,629 people across three local sites, ranking as the region’s second-largest manufacturer. Bausch + Lomb, headquartered in Vaughan, Ontario, with U.S. corporate offices in Bridgewater, N.J., employs 1,168 people locally and approximately 13,000 worldwide, with a presence in nearly 100 countries [2].
Cooper Cos. stock price saw a rise over 4% in premarket trading Monday following the announcement. While the potential merger is still in the early stages and has not been confirmed, it reflects Jana Partners’ push for strategic changes within the company.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet